Pfizer to Invest Nearly Half a Billion Dollars in Sterile Injectable Facility

USA: Sterile Injectables Pfizer to Invest Nearly Half a Billion Dollars in Sterile Injectable Facility

26.07.2018Editor: MA Alexander Stark

Pfizer is investing $ 465 million to build a technically advanced sterile injectable pharmaceutical production facility in Portage, Michigan.

Related Vendor

Pfizer Deutschland GmbH

Pfizer is going to build a cutting-edge sterile injectable facility in Michigan.
(Source: Pfizer)

New York/USA — Known as Modular Aseptic Processing (MAP), the new, multi-story, 37,000-m²-production facility will also create an estimated 450 new jobs over the next several years. This expands the company’s presence in Portage, located in Kalamazoo County, where the company now employs more than 2,200 people at one of its largest plants.

Ian Read, Chairman and Chief Executive Officer, said that this investment was part of the company's overall plan announced in January to invest approximately $ 5 billion in US-based capital projects as a result of the enactment of the Tax Cuts and Jobs Act. During the next six years, he expects to invest approximately $ 1.1 billion in Kalamazoo County — which was in addition to the $ 1 billion the company invested in the site over the past decade.

Pfizer and Zhejiang Hisun Pharmaceuticals have announced that Pfizer has sold 49 % of its equity share in its joint venture, Hisun-Pfizer Pharmaceuticals Co., to Sapphire I (HK) Holdings. (Deposit Photos)

Ron Perry, Site Leader for the Portage plant, said the new sterile injectable facility will strengthen the site’s role in Pfizer’s global network. Sterile drug product manufacturing was incredibly complex and this contemporary facility would combine cutting-edge technology and a highly talented workforce to assure the company remained a trusted and reliable supplier of these therapies to patients, he added.

MAP will incorporate technically advanced aseptic manufacturing equipment, systems and design, including multiple, self-contained modular manufacturing lines. This allows the manufacturing line in each module to be entirely separate from all other manufacturing lines. Groundbreaking is planned for spring 2019, with construction expected to be completed in 2021. After the facility is validated by regulatory agencies, production should begin in 2024.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:45418617)